Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.

Tantbirojn P, Triratanachat S, Trivijitsilp P, Niruthisard S.

J Med Assoc Thai. 2008 Aug;91(8):1161-5.

PMID:
18788685
2.

Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.

Shawana S, Kehar SI, Masood S, Aamir I.

J Coll Physicians Surg Pak. 2016 Apr;26(4):277-82. doi: 2291.

PMID:
27097697
3.
4.

Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma.

Lee H, Choi HJ, Kang CS, Lee HJ, Lee WS, Park CS.

Mod Pathol. 2012 Nov;25(11):1508-15. doi: 10.1038/modpathol.2012.111. Epub 2012 Jul 6.

5.
6.

[Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].

Xiong Y, Xiong YY, Zhou YF.

Zhonghua Bing Li Xue Za Zhi. 2009 Sep;38(9):594-9. Chinese.

PMID:
20079187
7.

Correlation between NDRG1 and PTEN expression in endometrial carcinoma.

Chen J, Li S, Yang Z, Lu G, Hu H.

Cancer Sci. 2008 Apr;99(4):706-10. doi: 10.1111/j.1349-7006.2008.00749.x.

9.

Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.

Buell-Gutbrod R, Cavallo A, Lee N, Montag A, Gwin K.

Int J Gynecol Pathol. 2015 Jan;34(1):65-73. doi: 10.1097/PGP.0000000000000106.

PMID:
25473755
10.

Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.

Quddus MR, Ologun BA, Sung CJ, Steinhoff MM, Lawrence WD.

Int J Gynecol Pathol. 2009 Sep;28(5):471-6. doi: 10.1097/PGP.0b013e3181a06f96.

PMID:
19696618
11.

Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.

Ip PP, Irving JA, McCluggage WG, Clement PB, Young RH.

Am J Surg Pathol. 2013 Feb;37(2):167-77. doi: 10.1097/PAS.0b013e318272d428.

PMID:
23211295
12.

Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.

Erkanli S, Kayaselcuk F, Kuscu E, Bagis T, Bolat F, Haberal A, Demirhan B.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1412-8.

PMID:
16803539
13.

Preoperative and postoperative correlation of histopathological findings in cases of endometrial hyperplasia.

Gundem G, Sendag F, Kazandi M, Akercan F, Mgoyi L, Terek MC, Zekioglu O.

Eur J Gynaecol Oncol. 2003;24(3-4):330-3.

PMID:
12807251
14.

PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma.

Pavlakis K, Messini I, Vrekoussis T, Panoskaltsis T, Chrissanthakis D, Yiannou P, Stathopoulos EN.

Gynecol Oncol. 2010 Dec;119(3):516-9. doi: 10.1016/j.ygyno.2010.08.023. Epub 2010 Sep 15.

PMID:
20833413
15.

Immunohistochemical phospho tensin tumor suppressor gene staining patterns in endometrial hyperplasias: a 2-year study.

Rao AC, Arya G, Padma PJ.

Indian J Pathol Microbiol. 2011 Apr-Jun;54(2):264-8. doi: 10.4103/0377-4929.81588.

16.

Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia.

Milam MR, Soliman PT, Chung LH, Schmeler KM, Bassett RL Jr, Broaddus RR, Lu KH.

Int J Gynecol Cancer. 2008 Jan-Feb;18(1):146-51. Epub 2007 Apr 26.

PMID:
17466036
17.

Diagnostic utility of phosphatase and tensin homolog, beta-catenin, and p53 for endometrial carcinoma by thin-layer endometrial preparations.

Norimatsu Y, Miyamoto M, Kobayashi TK, Moriya T, Shimizu K, Yanoh K, Tsukayama C, Miyake Y, Ohno E.

Cancer. 2008 Jun 25;114(3):155-64. doi: 10.1002/cncr.23495.

19.

Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.

McCampbell AS, Broaddus RR, Loose DS, Davies PJ.

Clin Cancer Res. 2006 Nov 1;12(21):6373-8.

20.

[Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].

Lax S.

Pathologe. 2011 Nov;32 Suppl 2:255-64. doi: 10.1007/s00292-011-1514-3. Review. German.

PMID:
22033684

Supplemental Content

Support Center